Analyst Says Affimed's 'Innate Cell Engagers Like No Others,' Sees Mammoth Upside

Retrieved on: 2022-12-12 20:13:27

Tags for this article:

Click the tags to see associated articles and topics

Analyst Says Affimed's 'Innate Cell Engagers Like No Others,' Sees Mammoth Upside. View article details on hiswai:

Excerpt

Latest Ratings for AFMD ; Oct 2021. Truist Securities. Initiates Coverage On. Buy ; Oct 2021. SVB Leerink. Maintains. Outperform ...

Article found on: finance.yahoo.com